Literature DB >> 27588831

Cysteine residues mediate high-affinity binding of thioredoxin to ASK1.

Salome Kylarova1,2, Dalibor Kosek1,2, Olivia Petrvalska1,2, Katarina Psenakova1,2, Petr Man3,4, Jaroslav Vecer5, Petr Herman5, Veronika Obsilova6, Tomas Obsil7,8.   

Abstract

Apoptosis signal-regulating kinase 1 (ASK1, MAP3K5) activates p38 mitogen-activated protein kinase and the c-Jun N-terminal kinase in response to proinflammatory and stress signals. In nonstress conditions, ASK1 is inhibited by association with thioredoxin (TRX) which binds to the TRX-binding domain (ASK1-TBD) at the N terminus of ASK1. TRX dissociates in response to oxidative stress allowing the ASK1 activation. However, the molecular basis for the ASK1:TRX1 complex dissociation is still not fully understood. Here, the role of cysteine residues on the interaction between TRX1 and ASK1-TBD in both reducing and oxidizing conditions was investigated. We show that from the two catalytic cysteines of TRX1 the residue C32 is responsible for the high-affinity binding of TRX1 to ASK1-TBD in reducing conditions. The disulfide bond formation between C32 and C35 within the active site of TRX1 is the main factor responsible for the TRX1 dissociation upon its oxidation as the formation of the second disulfide bond between noncatalytic cysteines C62 and C69 did not have any additional effect. ASK1-TBD contains seven conserved cysteine residues which differ in solvent accessibility with the residue C250 being the only cysteine which is both solvent exposed and essential for TRX1 binding in reducing conditions. Furthermore, our data show that the catalytic site of TRX1 interacts with ASK1-TBD region containing cysteine C200 and that the oxidative stress induces intramolecular disulfide bond formation within ASK1-TBD and affects its structure in regions directly involved and/or important for TRX1 binding.
© 2016 Federation of European Biochemical Societies.

Entities:  

Keywords:  zzm321990TRXzzm321990; ASK1; cysteine; disulfide bond; mass spectrometry

Mesh:

Substances:

Year:  2016        PMID: 27588831     DOI: 10.1111/febs.13893

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  10 in total

1.  Structural basis of autoregulatory scaffolding by apoptosis signal-regulating kinase 1.

Authors:  Johannes F Weijman; Abhishek Kumar; Sam A Jamieson; Chontelle M King; Tom T Caradoc-Davies; Elizabeth C Ledgerwood; James M Murphy; Peter D Mace
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-27       Impact factor: 11.205

Review 2.  Modulation of signaling mechanisms in the heart by thioredoxin 1.

Authors:  Narayani Nagarajan; Shinichi Oka; Junichi Sadoshima
Journal:  Free Radic Biol Med       Date:  2016-12-16       Impact factor: 7.376

3.  Cerium Oxide Nanoparticles Regulate Osteoclast Differentiation Bidirectionally by Modulating the Cellular Production of Reactive Oxygen Species.

Authors:  Kai Yuan; Jingtian Mei; Dandan Shao; Feng Zhou; Han Qiao; Yakun Liang; Kai Li; Tingting Tang
Journal:  Int J Nanomedicine       Date:  2020-08-25

4.  Redox-Inactive Peptide Disrupting Trx1-Ask1 Interaction for Selective Activation of Stress Signaling.

Authors:  Dilini N Kekulandara; Shima Nagi; Hyosuk Seo; Christine S Chow; Young-Hoon Ahn
Journal:  Biochemistry       Date:  2018-01-05       Impact factor: 3.162

5.  Mapping the phenotypic repertoire of the cytoplasmic 2-Cys peroxiredoxin - Thioredoxin system. 1. Understanding commonalities and differences among cell types.

Authors:  Gianluca Selvaggio; Pedro M B M Coelho; Armindo Salvador
Journal:  Redox Biol       Date:  2017-12-21       Impact factor: 11.799

Review 6.  Redox Regulation of Inflammatory Processes Is Enzymatically Controlled.

Authors:  Inken Lorenzen; Lisa Mullen; Sander Bekeschus; Eva-Maria Hanschmann
Journal:  Oxid Med Cell Longev       Date:  2017-10-08       Impact factor: 6.543

7.  Cold atmospheric plasma generated reactive species aided inhibitory effects on human melanoma cells: an in vitro and in silico study.

Authors:  Dharmendra Kumar Yadav; Manish Adhikari; Surendra Kumar; Bhagirath Ghimire; Ihn Han; Mi-Hyun Kim; Eun-Ha Choi
Journal:  Sci Rep       Date:  2020-02-25       Impact factor: 4.379

Review 8.  ASK1 inhibition: a therapeutic strategy with multi-system benefits.

Authors:  Jacqueline M Ogier; Bryony A Nayagam; Paul J Lockhart
Journal:  J Mol Med (Berl)       Date:  2020-02-14       Impact factor: 4.599

9.  Prdx1 Interacts with ASK1 upon Exposure to H2O2 and Independently of a Scaffolding Protein.

Authors:  Trung Nghia Vo; Julia Malo Pueyo; Khadija Wahni; Daria Ezeriņa; Jesalyn Bolduc; Joris Messens
Journal:  Antioxidants (Basel)       Date:  2021-06-30

Review 10.  Structural Insights Support Targeting ASK1 Kinase for Therapeutic Interventions.

Authors:  Veronika Obsilova; Karolina Honzejkova; Tomas Obsil
Journal:  Int J Mol Sci       Date:  2021-12-13       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.